Article
Peter Thiel joins funding round for peptide drug player in latest swing at emerging biotech market
Rating:
0.0
Views:
96
Likes:
1
Library:
1
For venture capitalists working in early-stage biotech, failures are more common than victories as investors search for novel pathways to treat well-trodden therapeutic areas. For the big-name investors, that's equally true — but if your name's Peter Thiel, a certain gravity and high expectations come with your money. Billionaire tech
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value